Desogestrel: Clinical Trials

8 trials of Desogestrel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 terminated, 1 unknown. 8 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Completed 6, Terminated 1, Unknown 1
Phase 32Completed 2
Phase 11Completed 1

Follow Desogestrel: new trials by email Literature Review of Desogestrel trials Research Report on Desogestrel

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo
Desogestrel Oral Tablet - Endometrioma
Phase 2 / Phase 3CompletedDepartment of Medical Services Ministry of Public Health of Thailand202021-06-012022-10-31
Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation Syndrome
Desogestrel - Congenital Central Hypoventilation Syndrome
Phase 2TerminatedChildren's Hospital Los Angeles12012-02-012023-11-18
A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women
desogestrel/ethinyl estradiol and ethinyl estradiol, desogestrel/ethinyl estradiol - Hemostasis, Oral Contraceptive
Phase 2CompletedTeva Branded Pharmaceutical Products R&D, Inc.2932011-10-312021-12-06
Assessment of Desogestrel in Ondine Syndrome
desogestrel - Ondine Syndrome
Phase 2 / Phase 3CompletedAssistance Publique - Hôpitaux de Paris62011-04-012013-11-14
A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
91-day Levonorgestrel Oral Contraceptive, 28-day Levonorgestrel Oral Contraceptive, 28-day Desogestrel Oral Contraceptive - Hemostasis, Oral Contraceptive
Phase 2CompletedTeva Women's Health2652010-11-012015-03-13
Evaluation of an Oral Contraceptive Containing 30 mg Ethinyloestradiol and 150 mg Desogestrel on Women's Health
Marvelon - Women With PMS
Phase 2UnknownTehran University of Medical Sciences612010-09-012010-12-08
Antagonist/Letrozole in Poor Responders
letrozole, oral contraceptive (Marvelone), GnRH agonist (buserelin) - Ovarian Stimulation
Phase 1 / Phase 2CompletedYazd Research & Clinical Center for Infertility1202008-06-012013-12-23
Feasibility Study Into the Contraceptive Effect of Estetrol
estetrol, estetrol and desogestrel, estetrol and progesterone - Healthy
Phase 2CompletedPantarhei Bioscience522007-11-012012-05-07

Conditions studied

Thrombosis (2)  ·  Congenital central hypoventilation syndrome (1)  ·  Endometriosis (1)  ·  Sleep Apnea, Central (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Children's Hospital Los Angeles (1)  ·  Department of Medical Services Ministry of Public Health of Thailand (1)  ·  Pantarhei Bioscience (1)  ·  Tehran University of Medical Sciences (1)  ·  Teva Branded Pharmaceutical Products R&D, Inc. (1)  ·  Teva Women's Health (1)  ·  Yazd Research & Clinical Center for Infertility (1)

Countries

Iran (2)  ·  Italy (2)  ·  United States (2)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Thailand (1)

Top investigators

H. Coelingh Bennink, MD, PhD (1)  ·  Iris Perez, MD (1)  ·  Ratchadaporn Roekyindee, MD (1)

Results publications

PMID 21801857, PMID 25268234, PMID 27328486, PMID 38336689